JNK1 and JNK2 Play Redundant Functions in Myc-induced B Cell Lymphoma Formation
Overview
Authors
Affiliations
JNK signaling as a target for anticancer therapy.
Abdelrahman K, Hassan H, Abdel-Aziz S, Marzouk A, Narumi A, Konno H Pharmacol Rep. 2021; 73(2):405-434.
PMID: 33710509 DOI: 10.1007/s43440-021-00238-y.
JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.
Du L, Anderson A, Nguyen K, Ojeda S, Ortiz-Rivera I, Nguyen T ACS Chem Biol. 2019; 14(7):1426-1435.
PMID: 31063355 PMC: 7181303. DOI: 10.1021/acschembio.9b00083.
The ERK and JNK pathways in the regulation of metabolic reprogramming.
Papa S, Choy P, Bubici C Oncogene. 2018; 38(13):2223-2240.
PMID: 30487597 PMC: 6398583. DOI: 10.1038/s41388-018-0582-8.
JNK signalling in cancer: in need of new, smarter therapeutic targets.
Bubici C, Papa S Br J Pharmacol. 2013; 171(1):24-37.
PMID: 24117156 PMC: 3874694. DOI: 10.1111/bph.12432.